跳至主要内容
临床试验/NCT00480103
NCT00480103终止3 期

Multi-Center Evaluation Program NCVD1H Intrauterine Embryo'S Development Assisted by ANECOVA ACVd1 Device

Instituto Valenciano de Infertilidad, IVI VALENCIA2 个研究点 分布在 1 个国家开始时间: 2007年8月1日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
发起方
试验地点
2

研究概览

简要总结

We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 36 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Women age below 37
  • Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)
  • Negative serologic screening for HIV, Hep B and C
  • No uterine or ovarian alterations found by ultrasound
  • Normal BMI (19 - 29 kg/m2).

排除标准

  • At least 8 stage MII oocytes are not retrieved
  • Endometriosis or PCO
  • Severe male factor in the partner

研究者

发起方
Instituto Valenciano de Infertilidad, IVI VALENCIA
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Intrauterine Embryo Development With ANECOVA Device | 临床试验